company background image
FHLT

Future Health ESG NasdaqCM:FHLT Stock Report

Last Price

US$10.01

Market Cap

US$250.3m

7D

0.1%

1Y

n/a

Updated

30 Sep, 2022

Data

Company Financials
FHLT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

FHLT Stock Overview

Future Health ESG Corp. does not have significant operations.

Future Health ESG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Future Health ESG
Historical stock prices
Current Share PriceUS$10.01
52 Week HighUS$10.84
52 Week LowUS$9.75
Beta0
1 Month Change0.60%
3 Month Change1.21%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO1.41%

Recent News & Updates

Shareholder Returns

FHLTUS Capital MarketsUS Market
7D0.1%-2.3%-2.5%
1Yn/a-25.4%-23.2%

Return vs Industry: Insufficient data to determine how FHLT performed against the US Capital Markets industry.

Return vs Market: Insufficient data to determine how FHLT performed against the US Market.

Price Volatility

Is FHLT's price volatile compared to industry and market?
FHLT volatility
FHLT Average Weekly Movementn/a
Capital Markets Industry Average Movement0.4%
Market Average Movement6.9%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market2.8%

Stable Share Price: Insufficient data to determine FHLT's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine FHLT's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2021n/aBrad Bostichttps://www.fhesg.com

Future Health ESG Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to pursue an initial business combination opportunity in the smart health technology sector.

Future Health ESG Fundamentals Summary

How do Future Health ESG's earnings and revenue compare to its market cap?
FHLT fundamental statistics
Market CapUS$250.25m
Earnings (TTM)-US$1.19m
Revenue (TTM)n/a

0.0x

P/S Ratio

-209.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
FHLT income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$1.19m
Earnings-US$1.19m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.048
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did FHLT perform over the long term?

See historical performance and comparison
We’ve recently updated our valuation analysis.

Valuation

Is FHLT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for FHLT?

Other financial metrics that can be useful for relative valuation.

FHLT key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does FHLT's PB Ratio compare to its peers?

FHLT PB Ratio vs Peers
The above table shows the PB ratio for FHLT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average7105.6x
SAMG Silvercrest Asset Management Group
1.8x7.0%US$238.3m
ASCB A SPAC II Acquisition
11436.8xn/aUS$251.7m
ATAK Aurora Technology Acquisition
16983.1xn/aUS$253.0m
ASA ASA Gold and Precious Metals
0.6xn/aUS$241.7m
FHLT Future Health ESG
n/an/aUS$250.3m

Price-To-Book vs Peers: FHLT is good value based on its Price-To-Book Ratio (-30x) compared to the peer average (7105.6x).


Price to Earnings Ratio vs Industry

How does FHLT's PE Ratio compare vs other companies in the US Capital Markets Industry?

Price-To-Book vs Industry: FHLT is good value based on its Price-To-Book Ratio (-30x) compared to the US Capital Markets industry average (-23.3x)


Price to Book Ratio vs Fair Ratio

What is FHLT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

FHLT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio-30x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate FHLT's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of FHLT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate FHLT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate FHLT's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

  • Take a look at our analysis of FHLT's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.

Future Growth

How is Future Health ESG forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


11.9%

Forecasted Diversified Financials industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Future Health ESG has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Discover growth companies

  • Take a look at our analysis of FHLT’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.

Past Performance

How has Future Health ESG performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


20.8%

Historical Diversified Financials annual earnings growth

Earnings and Revenue History

Quality Earnings: FHLT is currently unprofitable.

Growing Profit Margin: FHLT is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if FHLT's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare FHLT's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FHLT is unprofitable, making it difficult to compare its past year earnings growth to the Capital Markets industry (33.2%).


Return on Equity

High ROE: FHLT's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Discover strong past performing companies

Financial Health

How is Future Health ESG's financial position?

Financial Health Score

3/6

Financial Health Score 3/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: FHLT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: FHLT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: FHLT is debt free.

Reducing Debt: FHLT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: FHLT has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: FHLT has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 178.9% each year.


Discover healthy companies

Dividend

What is Future Health ESG current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage

Dividend Yield vs Market

Future Health ESG Dividend Yield vs Market
How does Future Health ESG dividend yield compare to the market?
SegmentDividend Yield
Company (Future Health ESG)n/a
Market Bottom 25% (US)1.7%
Market Top 25% (US)4.7%
Industry Average (Capital Markets)3.0%
Analyst forecast in 3 Years (Future Health ESG)n/a

Notable Dividend: Unable to evaluate FHLT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate FHLT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if FHLT's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if FHLT's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as FHLT has not reported any payouts.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

1.5yrs

Average board tenure


CEO

Brad Bostic (47 yo)

1.5yrs

Tenure

Mr. Bradley A. Bostic also known as Brad, serves as Chairman and Chief Executive Officer at Future Health ESG Corp. since February 25, 2021. He had been Director of Novus Capital Corporation since March 5,...


Board Members

Experienced Board: FHLT's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of FHLT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies132,7000.5%
General Public155,7160.6%
Individual Insiders2,144,1538.6%
VC/PE Firms2,625,00010.5%
Hedge Funds4,051,00016.2%
Institutions15,891,43163.6%

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Top Shareholders

Top 25 shareholders own 94.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.05%
Barclays PLC Private Banking & Investment Banking Investment
3,512,288$35.2m0%0.06%
10.5%
Health Cloud Capital
2,625,000$26.3m0%no data
8.28%
Magnetar Capital, LLC
2,071,000$20.7m5.77%0.28%
7.92%
Polar Asset Management Partners Inc.
1,980,000$19.8m0%0.36%
4.6%
Weiss Asset Management, LLC
1,150,000$11.5m-36.11%0.43%
4.45%
Bradley Bostic
1,111,451$11.1m0%no data
4.3%
Nomura Holdings Inc, Securities & Investment Arm
1,075,834$10.8m0%0.06%
4.24%
Highbridge Capital Management, LLC
1,059,992$10.6m-0.23%0.24%
4%
Travis Morgan
998,952$10.0m0%no data
3.92%
Angelo, Gordon & Co., L.P.
980,000$9.8m0%1.19%
3.92%
Tenor Capital Management Company, L.P.
979,900$9.8m0%1.11%
3.46%
Marshall Wace LLP
863,753$8.6m0%0.02%
2.94%
Citadel Advisors LLC
735,712$7.4m10.39%0.01%
2.6%
Bank of America Corporation, Asset Management Arm
650,000$6.5m0%no data
2.51%
CaaS Capital Management LP
627,089$6.3m0%0.92%
2.2%
Shaolin Capital Management LLC
550,002$5.5m0%0.27%
1.97%
Saba Capital Management, L.P.
491,898$4.9m0%0.07%
1.92%
MM Asset Management Inc
480,000$4.8m-51.02%0.3%
1.48%
JPMorgan Chase & Co, Brokerage and Securities Investments
369,073$3.7m0%no data
1.41%
First Trust Capital Management L.P.
352,096$3.5m0%0.29%
1.12%
State of Wisconsin Investment Board
280,000$2.8m19.51%0.01%
1%
Brookfield Asset Management Inc.
250,000$2.5m0%0.01%
0.8%
Millennium Management LLC
200,000$2.0m0%no data
0.66%
Periscope Capital Inc
165,267$1.7m0%0.05%
0.6%
Whitebox Advisors LLC
150,000$1.5m0%0.16%

Company Information

Future Health ESG Corp.'s employee growth, exchange listings and data sources


Key Information

  • Name: Future Health ESG Corp.
  • Ticker: FHLT
  • Exchange: NasdaqCM
  • Founded: 2021
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Implied Market Cap: US$250.250m
  • Shares outstanding: 25.00m
  • Website: https://www.fhesg.com

Location

  • Future Health ESG Corp.
  • 8 The Green
  • Suite 12081
  • Dover
  • Delaware
  • 19901
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
FHLT.UNasdaqCM (Nasdaq Capital Market)UnitsUSUSDSep 2021
FHLTNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDDec 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/09/30 00:00
End of Day Share Price2022/09/29 00:00
Earnings2022/06/30
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.